Position in LLY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,599,208,548
+$349,518,889 QoQ
Shares Held
1,333,307
-1.9% QoQ
Ownership
0.142%
of shares outstanding
% of Portfolio
1.21%
of 13F equity value
Holder Rank
#63
of 4,632 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 59%
Shared 0%
None 41%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $4,800,494,597 across 17 Drug Manufacturers - General names. LLY ranks #1 (33.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
1,333,307 | $1,599,208,548 | |
| 2 | JNJ |
Johnson & Johnson
|
3,780,752 | $960,197,585 | |
| 3 | ABBV |
AbbVie Inc.
|
2,733,648 | $687,895,182 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,809,518 | $489,523,063 | |
| 5 | AMGN |
Amgen Inc
|
904,954 | $327,701,942 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,051,819 | $259,226,812 | |
| 7 | PFE |
Pfizer Inc
|
8,609,603 | $207,319,240 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,347,347 | $192,874,134 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,599,208,548 | 1,333,307 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,249,689,659 | 1,358,698 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,493,332,479 | 1,389,560 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,099,342,608 | 1,440,816 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,142,053,544 | 1,465,054 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,235,330,931 | 1,495,721 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $1,149,345,108 | 1,488,789 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $1,341,896,108 | 1,514,658 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,429,958,982 | 1,579,402 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,198,556,294 | 1,540,640 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $898,085,607 | 1,540,667 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $835,136,169 | 1,554,812 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $724,665,082 | 1,545,194 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $524,911,631 | 1,528,483 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $537,789,190 | 1,470,012 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $456,320,250 | 1,411,227 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $448,324,169 | 1,382,735 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $387,030,773 | 1,351,506 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $367,750,192 | 1,331,367 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $302,468,710 | 1,309,105 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $309,067,500 | 1,346,582 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $264,443,710 | 1,415,500 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $255,198,958 | 1,511,484 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $227,412,895 | 1,536,366 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $254,667,150 | 1,551,146 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $201,427,127 | 1,452,041 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||